Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial

Genome-wide association studies (GWAS) were conducted in participants of the CO-MED (Combining Medications to Enhance Depression Outcomes) trial, a randomized, 3-treatment arm clinical trial of major depressive disorder (MDD) designed to identify markers of differential treatment outcome (response a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Neuropsychiatry
Päätekijät: Gadad, Bharathi S., Raj, Prithvi, Jha, Manish K., Carmody, Thomas, Dozmorov, Igor, Mayes, Taryn L., Wakeland, Edward K., Trivedi, Madhukar H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2018
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032036/
https://ncbi.nlm.nih.gov/pubmed/29998114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487321
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia